BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15933475)

  • 1. Neuroendocrine tumors of the gastrointestinal tract: recent advances in molecular genetics, diagnosis, and treatment.
    Oberg K
    Curr Opin Oncol; 2005 Jul; 17(4):386-91. PubMed ID: 15933475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology, diagnosis, and treatment of neuroendocrine tumors of the gastrointestinal tract.
    Oberg K
    Curr Opin Oncol; 1994 Jul; 6(4):441-51. PubMed ID: 7803546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New molecular aspects in the diagnosis and therapy of neuroendocrine tumors of the gastroenteropancreatic system.
    Pape UF; Höcker M; Seuss U; Wiedenmann B
    Recent Results Cancer Res; 2000; 153():45-60. PubMed ID: 10626288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine gastrointestinal tumours.
    Oberg K
    Ann Oncol; 1996 Jul; 7(5):453-63. PubMed ID: 8839899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin receptor scintigraphy in the diagnosis of neuroendocrine gastroenteropancreatic tumors.
    Bäder M; Koppenhagen K
    Recent Results Cancer Res; 1996; 142():137-62. PubMed ID: 8893340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State of the art and future prospects in the management of neuroendocrine tumors.
    Oberg K
    Q J Nucl Med; 2000 Mar; 44(1):3-12. PubMed ID: 10932597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostics and treatment of neuroendocrine tumors of the digestive tract in the light of the present standards].
    Szczeblowska D
    Pol Merkur Lekarski; 2007 May; 22(131):437-41. PubMed ID: 17679390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
    Oberg KE; Reubi JC; Kwekkeboom DJ; Krenning EP
    Gastroenterology; 2010 Sep; 139(3):742-53, 753.e1. PubMed ID: 20637207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine gastrointestinal tumors--a condensed overview of diagnosis and treatment.
    Oberg K
    Ann Oncol; 1999; 10 Suppl 2():S3-8. PubMed ID: 10399026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of false-positive findings of somatostatin receptor scintigraphy in diagnosis of neuroendocrine tumors of the gastroenteropancreatic system].
    Faiss S; Scherübl H; Bäder M; Fett U; Koppenhagen K; Wiedenmann B; Riecken EO
    Z Gastroenterol; 1994 May; 32(5):243-6. PubMed ID: 7915450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of gastrointestinal neuroendocrine tumors.
    Modlin IM; Basson MD; Mani S
    Gastroenterologist; 1993 Mar; 1(1):59-70. PubMed ID: 8049881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine tumor disease: an evolving landscape.
    Frilling A; Akerström G; Falconi M; Pavel M; Ramos J; Kidd M; Modlin IM
    Endocr Relat Cancer; 2012 Oct; 19(5):R163-85. PubMed ID: 22645227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroendocrine tumors of the gastrointestinal tract].
    Arnold C
    Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polish diagnostic and therapeutic guidelines in gastroenteropancreatic neuroendocrine tumors (GEP NET)].
    Kos-Kudła B;
    Endokrynol Pol; 2006; 57(3):267-72. PubMed ID: 17111342
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Starker LF; Carling T
    Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
    Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
    Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Localization diagnostics of neuroendocrine gastrointestinal tumours].
    Kjaer A; Knigge U; Mortensen J; Hansen CP; Fallentin E
    Ugeskr Laeger; 2010 Oct; 172(43):2953-6. PubMed ID: 21040674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors.
    Waser B; Rehmann R; Sanchez C; Fourmy D; Reubi JC
    J Clin Endocrinol Metab; 2012 Feb; 97(2):482-8. PubMed ID: 22112810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic monitoring of gastroenteropancreatic neuroendocrine tumors: the challenges ahead.
    Sundin A; Rockall A
    Neuroendocrinology; 2012; 96(4):261-71. PubMed ID: 22907438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract.
    Modlin IM; Kidd M; Bodei L; Drozdov I; Aslanian H
    Am J Gastroenterol; 2015 Aug; 110(8):1223-32. PubMed ID: 26032155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.